title: Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease.
abstract: The loss of intestinal epithelial cell (IEC) function is a critical component in the initiation and perpetuation of chronic intestinal inflammation in the genetically susceptible host. We applied proteome analysis (PA) to characterize changes in the protein expression profile of primary IEC from patients with Crohn's disease (CD) and ulcerative colitis (UC). Surgical specimens from 18 patients with active CD (N = 6), UC (N = 6), and colonic cancer (N = 6) were used to purify primary IEC from ileal and colonic tissues. Changes in protein expression were identified using 2D-gel electrophoreses (2D SDS-PAGE) and peptide mass fingerprinting via MALDI-TOF mass spectrometry (MS) as well as Western blot analysis. PA of primary IEC from inflamed ileal tissue of CD patients and colonic tissue of UC patients identified 21 protein spots with at least 2-fold changes in steady-state expression levels compared to the noninflamed tissue of control patients. Statistical significance was achieved for 9 proteins including the Rho-GDP dissociation inhibitor alpha that was up-regulated in CD and UC patients. Additionally, 40 proteins with significantly altered expression levels were identified in IEC from inflamed compared to noninflamed tissue regions of single UC (N = 2) patients. The most significant change was detected for programmed cell death protein 8 (7.4-fold increase) and annexin 2A (7.7-fold increase). PA in primary IEC from IBD patients revealed significant expression changes of proteins that are associated with signal transduction, stress response as well as energy metabolism. The induction of Rho GDI alpha expression may be associated with the destruction of IEC homeostasis under condition of chronic intestinal inflammation.
authors.affiliation: Else-Kroener-Fresenius Center for Experimental Nutritional Medicine, Molecular Nutrition, Technical University of Munich, Freising-Weihenstephan, Germany.
authors.forename: Anna
authors.initials: A
authors.lastname: Shkoda
authors.forename: Tanja
authors.initials: T
authors.lastname: Werner
authors.forename: Hannelore
authors.initials: H
authors.lastname: Daniel
authors.forename: Manuela
authors.initials: M
authors.lastname: Gunckel
authors.forename: Gerhard
authors.initials: G
authors.lastname: Rogler
authors.forename: Dirk
authors.initials: D
authors.lastname: Haller
mesh_terms: D017209:Apoptosis; D015153:Blotting, Western; D003093:Colitis, Ulcerative / Q000473:pathology; D003110:Colonic Neoplasms / Q000473:pathology; D003424:Crohn Disease / Q000473:pathology; D015180:Electrophoresis, Gel, Two-Dimensional; D004734:Energy Metabolism; D005786:Gene Expression Regulation; D020730:Guanine Nucleotide Dissociation Inhibitors / Q000032:analysis* / Q000235:genetics; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000473:pathology*; D007413:Intestinal Mucosa / Q000737:chemistry*; D011506:Proteins / Q000032:analysis*; D040901:Proteomics / Q000379:methods*; D015398:Signal Transduction; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D013312:Stress, Physiological; D015854:Up-Regulation; D062947:rho-Specific Guanine Nucleotide Dissociation Inhibitors
chemical_list: D020730:Guanine Nucleotide Dissociation Inhibitors; D011506:Proteins; D062947:rho-Specific Guanine Nucleotide Dissociation Inhibitors